NAKUP ZDRAVIL PALIVIZUMAB IN CEPIVA PROTI TUBERKOLOZI
Awarded
The competition has ended and a winner has been selected.
Brief
Farmasøytisk engroshandel
NACIONALNI INŠTITUT ZA JAVNO ZDRAVJE je sklenil okvirni sporazum z AstraZeneca AB za dobavo zdravil Palivizumab in cepiva proti tuberkulozi, z ocenjeno skupno maksimalno vrednostjo 2.368.329 EUR. Pri izbiri je bila uporabljena najnižja cena brez DDV kot edino merilo za dodelitev.
Result
- Winner
- AstraZeneca AB
- Number of bids
- 1
- Contract value
- Not stated
- Maximum framework agreement value
- Up to €2,001,924
About the bid
- Contact phone
- 012441400
- Contact email
- info@nijz.si
- Address
- Trubarjeva cesta002, 1000 Ljubljana
NAKUP ZDRAVIL PALIVIZUMAB IN CEPIVA PROTI TUBERKOLOZI
Custom Assessment Criteria
Start a free trial to ask your own questions about the tender and get AI-generated answers.
Award Criteria
Description
Najnižja cena brez DDV.
Qualification requirements
Found no qualification requirements in the contract notice.
Previous Contract Winners
Start a free trial to see who has won similar tenders for this buyer.
See the full notice
- Contracting authority
- NACIONALNI INŠTITUT ZA JAVNO ZDRAVJE
- Title
- NAKUP ZDRAVIL PALIVIZUMAB IN CEPIVA PROTI TUBERKOLOZI
- Type
- Main code
- Supplemental codes
- Location
- Osrednjeslovenska
- Estimated value
- €2,368,329.00
ResultFramework agreementPrequalification
33600000Pharmaceutical products
No supplemental codes from buyer…